![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Charioteer Pharmaceutical Co., Ltd Xianju Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Clopidogrel hydrogen sulfate, Process III, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2024-084 - Rev 00
This Chemical Type CEP, issued on June 06, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2531 associated with this CEP further emphasizes